MD MOYEN UDDIN PK | Molecular Medicine | Best Researcher Award

Published on by Research Awards

Dr. MD MOYEN UDDIN PK | Molecular Medicine | Best Researcher Award

Scientist at eEarning Bangladesh, Bangladesh

Dr. Md. Moyen Uddin PK is a distinguished researcher and academic in biochemistry and medicinal chemistry, currently serving as Adjunct Faculty at Independent University of Bangladesh and previously as a Senior Lecturer at Primeasia University. His education includes a Ph.D. in Medicinal Chemistry from Rajshahi University and earlier degrees in Biochemistry and Molecular Biology, where he achieved first-class honors. His research interests encompass protein chemistry, molecular immunology, neurobiology, and medicinal chemistry. He has published extensively on topics related to polysaccharides, cancer treatment, and antioxidant activities. Dr. Uddin’s technical skills include advanced molecular biology techniques, protein chemistry methods, analytical chemistry, and computer-aided drug design. He has received multiple awards for academic excellence and contributions to research, including merit scholarships and recognition for his exceptional academic performance. 🧪📚🏆

Professional Profiles:

🎓 Education

Dr. Md. Moyen Uddin PK has an extensive academic background in the field of biochemistry and medicinal chemistry. He is currently pursuing a Ph.D. in Medicinal Chemistry at Rajshahi University, focusing on identifying novel anticancer polysaccharides from Pleurotus ostreatus, with an expected degree completion in August 2024. Dr. Uddin earned his Master’s and Bachelor’s degrees in Biochemistry and Molecular Biology from Rajshahi University, graduating with First Class honors and securing the top position in both programs. His undergraduate studies spanned from January 2000 to December 2003, and his Master’s from January 2004 to December 2004. Prior to his higher education, he completed his Higher Secondary Certificate and Secondary School Certificate with First Division in the Science Group at N S Govt. College and Sadhanpur High School, respectively.

Professional Experience

Dr. Md. Moyen Uddin PK has accumulated extensive experience in both academic and clinical settings. He has been serving as an Adjunct Faculty at the Department of Biochemistry & Biotechnology, Independent University of Bangladesh (IUB) since September 2017. Prior to this role, he was a Senior Lecturer at Primeasia University’s Department of Biochemistry & Molecular Biology from January 2016 to March 2017, and a Lecturer in the same department from February 2012 to December 2015. Dr. Uddin also worked as a Consultant Biochemist at Anwer Khan Medical College & Hospital Ltd. from January 2008 to December 2011. His earlier experience includes a position as a Research Assistant at the Protein Research Laboratory, Department of Biochemistry & Molecular Biology, Rajshahi University, from July 2007 to December 2007.

Research Interest

Dr. Md. Moyen Uddin PK’s research interests are diverse and encompass several advanced fields. He focuses on Protein Chemistry, including the study of protein interactions and structural biology. In Cell Biology, he investigates cellular processes and mechanisms underlying disease. His work in Molecular Immunology explores immune responses at a molecular level, while in Neurobiology, he studies the molecular basis of neural function and disorders. Bioinformatics is another key area, where he applies computational tools to analyze biological data. He is also engaged in research on the Molecular Basis of Diseases, examining how genetic and environmental factors contribute to disease. In Radiation Genetics, he explores the impact of radiation on genetic material, and his work in Computer-Aided Drug Design involves using computational methods to develop new therapeutic agents. His studies in Medicinal Chemistry focus on discovering and optimizing bioactive compounds for therapeutic use.

Award and Honors

Dr. Md. Moyen Uddin PK has received several notable awards and honors throughout his academic career. He earned a University Award for securing the 1st Class 1st position in his B.Sc. (Hon’s) at Rajshahi University in 2003. Additionally, he was awarded a Gold Medal for achieving 1st Class 1st positions in both B.Sc. and M.Sc. (Thesis) from his residential hall at Rajshahi University. His academic excellence was further recognized with a Merit Scholarship at both undergraduate and graduate levels at Rajshahi University. Furthermore, he obtained an Honor Code Certificate from HarvardedX for completing PH525.1x: Data Analysis for Life Sciences 1: Statistics and R, highlighting his proficiency in statistical analysis and data interpretation. 🏅🎓

Research Skills

Dr. Md. Moyen Uddin PK possesses a broad range of research skills essential for his work in biochemistry and medicinal chemistry. His Molecular Biology expertise includes techniques such as agarose gel electrophoresis, SDS-PAGE for DNA isolation, real-time PCR, various microscopy techniques, DNA recombinant synthesis, plasmid DNA culture, and ELISA. In Protein Chemistry, he is proficient in SDS-PAGE, Western blotting, gel filtration chromatography, thin layer chromatography, and affinity chromatography. His Analytical Chemistry skills cover infrared spectroscopy, NMR, GC-MS, and HPLC. In Computer-Aided Drug Design (CADD), Dr. Uddin uses tools like LigPlot+, Gaussian, VMD, NAMD, WebMO, GabEdit, and AutoDock Vina. For Bioinformatics, he utilizes software such as DNA Star Lasergene, MEGA, BLAST, ExPASy, PDB, ClustalW, Phylogeny.fr, and Pymol. Additionally, he is adept at Statistical Analysis using R, GraphPad Prism, SPSS, AMOS, and STATA. 🔬🧬📊

Publications

  • “Antioxidant of Pleurotus ostreatus (Jacq.) P. Kumn and lymphoid cancer cells”
    Authors: Pk, M.M.U., O’Sullivan, J., Pervin, R., Rahman, M.
    Published in: Cancer: Oxidative Stress and Dietary Antioxidants, 2021, pp. 427–437
  • “Investigating the efficiency of APRI, FIB-4, AAR and AARPRI as noninvasive markers for predicting hepatic fibrosis in chronic hepatitis B patients in Bangladesh”
    Authors: Sha, F.R., Pk, M.U., Abuelezz, N.Z., Begum, M., Rahman, M.
    Published in: Open Microbiology Journal, 2019, 13(1), pp. 34–40
  • “Control of early blight of tomato caused by Alternaria solani and screening of tomato varieties against the pathogen”
    Authors: Roy, C.K., Akter, N., Sarkar, M.K.I., Zenat, E.A., Jahan, M.A.A.
    Published in: Open Microbiology Journal, 2019, 13(1), pp. 41–50
  • “Effect of solvents on phytochemicals content and antioxidant activity of Ganoderma lucidum”
    Authors: Pk, M.U., Talukder, R.I., Sarkar, M.K.I., Zenat, E.A., Akther, L.
    Published in: Open Microbiology Journal, 2019, 13(1), pp. 10–15

 

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Published on by Research Awards

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Dr Ferdinando D’Amico, IRCCS San Raffaele Hospital, Italy

Dr. Ferdinando D’Amico is a distinguished gastroenterologist at IRCCS San Raffaele Hospital in Milan, Italy, with expertise in gastroenterology and endoscopy. 🎓 He completed his residency in Gastroenterology/Digestive Diseases and earned his PhD at Hunimed University, focusing on histology in inflammatory bowel diseases. His academic journey includes a degree in Medicine and Surgery from “Cattolica del Sacro Cuore” University, where he researched intestinal permeability and atherosclerosis. 🏥 His training included internships in gastroenterology and cardiology at “Agostino Gemelli” Hospital in Rome. Dr. D’Amico is proficient in English and French, and skilled in digital communication. 🌍🔬

Publication profile

Scopus

Education 

🎓 From 2003 to 2008, attended Classical High School, graduating with highest honours. From 2009 to 2015, pursued a Degree in Medicine and Surgery at “Cattolica del Sacro Cuore” University, Rome, also graduating with highest honours. 🏆 The dissertation, titled “Alterations in Intestinal Permeability and Inflammation: A Novel Potential Mechanism of Atherosclerosis,” was supervised by Professor Filippo Crea. 📜 Currently registered with the Ordine Provinciale dei Medici Chirurghi e degli Odontoiatri di Caserta, registration number 7593. 🩺

Experience

From November 1, 2016, to November 2, 2020, [Name] completed their residency in Gastroenterology/Digestive System Diseases at Hunimed University in Pieve Emanuele, Italy, graduating with highest honors. They then pursued a Ph.D. at the same institution, focusing on “The Role of Histology in Inflammatory Bowel Diseases,” under the guidance of Prof. Silvio Danese. From January 1, 2021, to February 9, 2024, they worked as a Gastroenterologist at the IRCCS San Raffaele Hospital in Milan, Italy, in the Gastroenterology and Endoscopy Unit, also directed by Prof. Silvio Danese. 🏥📚🩺

Research focus

Based on the provided publications, the research focus appears to be on inflammatory bowel diseases (IBD), specifically Crohn’s disease and ulcerative colitis. The studies address various aspects such as comparing treatments (e.g., tofacitinib vs. ustekinumab), assessing remission through non-invasive methods, and evaluating regulatory guidance for JAK inhibitors. The research also explores the use of biologics and other therapies in managing IBD, including switching between different treatment forms. This indicates a strong emphasis on optimizing treatment strategies and improving patient outcomes in IBD. 🌟📚💊

Publication top notes

Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study

Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn’s disease: a prospective cohort study

Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study

The role of filgotinib in ulcerative colitis and Crohn’s disease

A new national survey of centers for cognitive disorders and dementias in Italy

An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study

Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn’s disease

MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations

Advancing transmural remission as a treatment target in Crohn’s disease: The future of tight-control strategy?

Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease